Latest Board Transitions News

GreenTech Metals has consolidated a dominant West Pilbara position by acquiring 70% of the Munni Munni PGE-Cu-Ni Project and completed a cost-saving Phase 1 drilling and historic core resampling program. Early data hints at significant resource expansion ahead of a JORC 2012 upgrade.

Energy Action Limited posted a milestone quarter ending March 2026, delivering positive operating cash flow for the first time in FY26 alongside strong revenue gains and a notable $0.5 million debt repayment. Governance changes add a layer of uncertainty ahead of a scheduled general meeting.

Alligator Energy has appointed Dr Andrea Marsland-Smith as Managing Director in addition to her CEO role, while preparing for the retirement of veteran Non-Executive Director Peter McIntyre following a key project milestone.

Island Pharmaceuticals reports a 213.8% increase in half-year loss to $4.81 million, driven by strategic acquisition and clinical development investments. The company advances its antiviral portfolio with Galidesivir and ISLA-101, supported by strong US regulatory engagement and a $9 million capital raise.

Woodside Energy Group Ltd reported record production and a net profit after tax of $2.7 billion in 2025, advancing key LNG and ammonia projects while achieving its 15% emissions reduction target.

ChemX Materials Limited has completed its Deed of Company Arrangement and appointed a new board, yet remains suspended from ASX trading while relying on director-related funding. The company is focused on stabilisation and exploring future opportunities.

Thunderbird Resources has appointed Scott Funston as a Non-Executive Director, bringing over two decades of mining and financial expertise, while Robin Wilson steps down but remains a consultant.

Wide Open Agriculture shakes up its leadership with a new board appointment and plans to recruit a CEO experienced in scaling plant protein businesses, signaling a strategic push to globalise its lupin protein technology.

Synertec Corporation reported resilience in FY25 despite sector headwinds, with a strong rebound in engineering profits and a 90% revenue jump in its renewable Powerhouse technology.

SGH Ltd reported record earnings and reaffirmed its FY26 EBIT growth guidance at its 2025 AGM, while addressing recent workplace fatalities and outlining strategic growth initiatives.

Group One Capital Limited reports initial $600,000 fee income from its subsidiary FSU Capital, with a $16 million fee pipeline and refreshed board governance signaling strategic momentum.

Nyrada has completed its Phase I trial for Xolatryp, confirming safety and predictable pharmacokinetics, while securing AU$8.25 million to fund an upcoming Phase IIa trial targeting heart attack patients.